June 22, 2011 — The US Food and Drug Administration (FDA) late yesterday approved the first autologous aesthetic cell therapy to improve the appearance of moderate to severe nasolabial fold wrinkles in adults.
The product, azficel-T (Laviv), is from Fibrocell Science, Inc, a company focused on developing personalized cell therapies for aesthetic, medical, and scientific applications.
According to the company, creating azficel-T involves a patented technology whereby fibroblasts are extracted from behind the patient’s ear and sent to the Fibrocell Science laboratory, where they are multiplied for about 3 months and then frozen until needed.
Over a series of 3 treatment sessions, typically 3 to 6 weeks apart, they are injected into nasolabial folds to reduce the appearance of smile lines.
Here is another product that is going to hit the market. we will keep our eyes open and see how things develop. For me to offer this product to my patients in Morristown New Jersey , I have to first make sure it is safe, it lasts as long lasting as the established long lasting products like Radiesse and Juvederm Ultra Plus. We also have to make sure this product is cost competitive.